O.9 Capecitabine (XELODA®, X) and oxaliplatine (ELOXATIN®, LOHP) regimen (XELOX) in elderly patients with metastatic colorectal cancer (MCRC): a FNCLCC French Collaborative Group GERICO 02 phase II study
Titel:
O.9 Capecitabine (XELODA®, X) and oxaliplatine (ELOXATIN®, LOHP) regimen (XELOX) in elderly patients with metastatic colorectal cancer (MCRC): a FNCLCC French Collaborative Group GERICO 02 phase II study
Auteur:
Rousseau, F. Bugat, R. Ducreux, M. Cvitkovic, F. Carola, E. Gisselbrecht, M. Esterni, B. Gouttenoire, F. Viret, F.